Tc99mGlucoheptonateQualityChecker
Tc-99m Glucoheptonate Quality Checker
Utility description: Tc-99m Glucoheptonate Quality Checker
Tc-99m Glucoheptonate Quality Checker — Technetium-99m Glucoheptonate for kidney and brain imaging
ℹ️ Utility checks critical parameters of Tc-99m Glucoheptonate (GH):
• Radiochemical purity (≥95%)
• Free pertechnetate (≤5%)
• Reduced/hydrolyzed technetium (≤5%)
• pH (4.5-7.5), Aluminum (<5 ppm)
• Stability (≤6 hours) — PRONE TO OXIDATION!
⚠️ CRITICAL: Glucoheptonate is less stable than DTPA or MAG3!
Use after 6 hours leads to accumulation in liver and thyroid gland.
Used for renal cortical scintigraphy (especially in pediatrics) and brain imaging.
Usage:
Tc99mGlucoheptonateQualityChecker.exe → demo mode (console output)
Tc99mGlucoheptonateQualityChecker.exe input.csv output.json → evaluate your data
Input format:
BatchNumber,RadiochemicalPurityPercent,FreePertechnetatePercent,ReducedHydrolyzedTechnetiumPercent,AluminumOxidePPM,pH,EndotoxinsEU_per_mL,SterilityTest,HeavyMetalsPPM,HoursSincePreparation,ActivityMBq
Example:
TC99M-GH-2026-001,97.0,1.5,1.5,3.0,6.0,40.0,0,4.0,3.0,700.0
— WHY IS THIS NEEDED?
Technetium-99m Glucoheptonate (GH) is a unique dual-action radiopharmaceutical:
• 6.02-hour half-life, 140 keV gamma radiation.
• Mechanism: rapid glomerular filtration + slow binding to proximal tubules.
• Allows assessment of both kidney function (early phases) and cortical anatomy (late phases).
• Penetrates disrupted blood-brain barrier, making it useful for diagnosing brain tumors and abscesses.
• Often used in pediatrics due to favorable dosimetry.
⚠️ CRITICAL:
• Radiochemical purity ≥95% — GH complex is less robust than DTPA/MAG3 and dissociates more easily.
• Free pertechnetate ≤5% — accumulates in thyroid and stomach, masking pathology.
• Reduced technetium ≤5% — colloids are taken up by liver, creating background during kidney studies.
• Usage time ≤6 hours — CRITICAL PARAMETER! GH is subject to oxidation and transchelation faster than other agents. After 6 hours, RCP may drop sharply.
• pH 4.5-7.5 — necessary to prevent hydrolysis and ensure biocompatibility.
• Aluminum <5 ppm — excess Al³⁺ catalyzes GH complex decomposition.
Key features:
• Strict stability time control (6 hours vs 8-12 for other drugs).
• Check of all standard safety parameters (sterility, endotoxins, heavy metals).
• Suitability assessment for two types of studies (kidneys and brain).
• Compliance with Ph. Eur. monograph on Technetium (99mTc) gluconate/glucoheptonate.
Critical parameters:
• Radiochemical purity: ≥95.0%
• Free pertechnetate: ≤5.0%
• Reduced technetium: ≤5.0%
• Aluminum oxide: <5.0 ppm
• pH: 4.5–7.5
• Endotoxins: <175 EU/mL
• Sterility: no growth
• Heavy metals: ≤10 ppm
• Stability time: ≤6 hours
• Minimum activity: ≥200 MBq
💡 Usage tips:
1. Prepare the drug immediately before use, avoid prolonged storage.
2. Do not use the drug if it has changed color or become turbid (sign of Sn²⁺ oxidation).
3. Brain studies require higher doses, so check activity carefully.
4. If RCP <95%, use only for qualitative assessment, not quantitative.
5. Store the kit in the refrigerator and protect from light to extend lyophilizate shelf life.
⚠️ Note: Tc-99m GH occupies a niche between purely filtration (DTPA) and purely secretory (MAG3) drugs. Its ability to fixate in the renal cortex allows obtaining excellent static images, but this feature requires impeccable radiochemical purity, as free technetium can also weakly bind to tissues, distorting the picture.input.csv
BatchNumber,RadiochemicalPurityPercent,FreePertechnetatePercent,ReducedHydrolyzedTechnetiumPercent,AluminumOxidePPM,pH,EndotoxinsEU_per_mL,SterilityTest,HeavyMetalsPPM,HoursSincePreparation,ActivityMBq TC99M-GH-2026-001,97.0,1.5,1.5,3.0,6.0,40.0,0,4.0,3.0,700.0 TC99M-GH-2026-002,94.0,4.0,2.0,4.5,6.5,80.0,0,6.0,5.5,500.0 TC99M-GH-2026-003,88.0,7.0,5.0,6.0,7.8,200.0,1,12.0,7.0,150.0
URS & FS — user requirements and functional specification
URS — User Requirements Specification
- The utility shall accept
input.csvwith the headers defined by the data contract. - Before calculation, the utility shall detect missing fields, type errors and invalid values.
- The utility shall deterministically perform “Tc-99m Glucoheptonate Quality Checker”.
- The checks shall include the following criteria: Radiochemical purity: ≥95.0%; Free pertechnetate: ≤5.0%; Reduced technetium: ≤5.0%; Aluminum oxide: <5.0 ppm; pH: 4.5–7.5; Endotoxins: <175 EU/mL; Sterility: no growth; Heavy metals: ≤10 ppm; Stability time: ≤6 hours; Minimum activity: ≥200 MBq.
- Each processed record shall receive a clear PASS, WARNING or FAIL status with the reason.
- The result shall be written to
output.jsonand retain the source values used for the checks. - The result supports batch-data review; release remains with authorised QA/QC personnel.
FS — Functional Specification
- Run
Tc99mGlucoheptonateQualityChecker.exein demo mode or withinput.csv output.jsonarguments. - Read UTF-8 CSV and validate the header and mandatory columns.
- Convert values to the expected types and validate admissibility.
- Perform the calculation or rule checks for “Tc-99m Glucoheptonate Quality Checker”.
- Create individual check results and the overall status.
- Write machine-readable JSON; invalid input shall not appear as a successful result.
input.csv example
BatchNumber,RadiochemicalPurityPercent,FreePertechnetatePercent,ReducedHydrolyzedTechnetiumPercent,AluminumOxidePPM,pH,EndotoxinsEU_per_mL,SterilityTest,HeavyMetalsPPM,HoursSincePreparation,ActivityMBq TC99M-GH-2026-001,97.0,1.5,1.5,3.0,6.0,40.0,0,4.0,3.0,700.0
Minimum output.json structure
{
"utility": "Tc99mGlucoheptonateQualityChecker",
"source": "input.csv",
"status": "PASS|WARNING|FAIL",
"checks": [
{
"parameter": "example",
"status": "PASS",
"message": "criterion satisfied"
}
],
"errors": []
}
Before operational use
- Limits and coefficients shall be approved before operational use.
- After an executable or rule change, repeat the affected tests.
- Retain the source CSV and JSON result together in the controlled process.
Included in packages
Radiopharmaceutical Diagnostics and Therapy QC Suite
36 utilities for clinically oriented radiopharmaceutical and workflow quality control: PET/SPECT tracers, the Tc-99m renal workflow, PRRT, PSMA therapy, targeted alpha therapy, radioembolization, bone-pain palliation, immuno-PET and generator-based radionuclide control.
OpenRPH isotope family: Tc-99m
Tc-99m radiopharmaceuticals, kit preparation, generator control, SPECT workflows and calculation utilities.
OpenRPH organ/system: brain and CNS
Brain perfusion, dopamine transporter, amyloid/tau, receptor imaging and neurological SPECT/PET.
OpenRPH organ/system: endocrine, thyroid and NET
Radioiodine, thyroid/parathyroid, somatostatin receptor, MIBG and neuroendocrine workflows.
OpenRPH organ/system: hepatobiliary and GI
HIDA, mebrofenin, gallbladder, gastric emptying, GI transit, bleeding and liver/spleen imaging.
OpenRPH organ/system: oncology and theranostics
Tumour imaging, PSMA/FAPI/receptor tracers, immuno-PET, targeted radionuclide therapy and radioembolization.
OpenRPH organ/system: renal and urinary
Renography, GFR/ERPF, renal uptake, DMSA/MAG3/DTPA and bladder-related workflows.
OpenRPH Tc-99m Renal Radiopharmaceutical and Imaging QC Suite
16 utilities covering the Tc-99m renal workflow: generator eluate and Mo-99 breakthrough, Sn(II), labeling stoichiometry and pH, radiochemical purity and stability of MAG3, DTPA, DMSA(III) and glucoheptonate, gamma-camera uniformity, renal uptake and plasma clearance, bladder voiding efficiency, patient dosimetry and decay-in-storage waste management.
OpenRPH use case: Tc-99m renal and nephrourology
Renal radiopharmaceuticals and calculation workflows: MAG3, DTPA, DMSA, glucoheptonate, generator Tc-99m, dynamic renography, GFR/ERPF and dosimetry.
OpenRPH workflow: dosimetry and therapy planning
Activity planning, absorbed dose, organ dose, lung shunt, preplanning and therapy verification.
OpenRPH workflow: imaging QC and quantitative interpretation
Acquisition, uptake, clearance, perfusion, transit, ejection fraction, segmentation and quantitative imaging.
OpenRPH workflow: product release QC
Assay, purity, sterility, endotoxins, pH, impurities, appearance and batch-release checks.
OpenRPH workflow: stability, storage, decay and waste
Kinetic stability, shelf life, decay correction, expiry, storage, trend and radioactive waste.
OpenRPH workflow: synthesis, labelling and kit reconstitution
Radiolabelling, synthesis, chelation, reducing agent, pH/stoichiometry and kit preparation.
Open